CBT in Adolescents With Type 1 Diabetes
The effectiveness of cognitive behavioural therapy (CBT) for adolescents with type 1 diabetes will be tested. This structured, time-limited, problem-orientated therapy will be used to impact on psychosocial factors influencing diabetic control, with the patient and therapist working together on specific goals to develop adaptive strategies.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Randomised Controlled Trial of Cognitive Behaviour Therapy: Efficacy and Acceptability for Adolescents With Type 1 Diabetes.|
- Well Being Questionnaire, Children’s Health locus of control,
- Diabetes Quality of Life for Youths (modified from DCCT),
- Self Efficacy for Diabetes Scale (modified version,),
- Diabetes Family Behaviour Scale, Diabetes Readiness to Change Questionnaire,
- Modified Health Care Climate Questionnaire (at baseline only).
|Study Start Date:||September 2001|
|Estimated Study Completion Date:||June 2005|
Ninety 11-16 year olds with T1DM (duration >1 year), attending paediatric diabetes outpatient clinics based in 4 centres in South-West England, UK, will be recruited to a randomised controlled trial of one to one sessions of CBT versus non-directive supportive counselling. Participants will attend up to 6 sessions (weekly) with either a CBT therapist or a counsellor, with 2 further sessions at 6 and 12 months. Follow up will continue for 12 months post intervention. HbA1c is the primary outcome measure. Psychological measures will also be measured.
|Bristol Royal Hospital for Children|
|Bristol, United Kingdom, BS2 8BJ|
|Principal Investigator:||Elizabeth C Crowne, MD||UBHT|
|Study Chair:||Ruth J Allen, PhD||University of Bristol|